Moreover, Badrinath, Set al. developed a vaccine that inhibits the hydrolytic shedding of MICA/B proteins from tumor cells, which induces tumor immunity via T and NK cells while avoiding the induction of antibodies that may block NKG2D receptor binding. The gene discussed is MICA; the disease is neoplasm.